Skip to main content

Table 1 Correlation of clinicopathological features of HNSCC patients with GLUT4 expression

From: Glucose transporter 4 promotes head and neck squamous cell carcinoma metastasis through the TRIM24-DDX58 axis

Clinicopathological feature Number GLUT4 expression, n (%) P
Low (n = 23) High (n = 67)
Age (years)
 <65 72 19 (26.4) 53 (73.6) 0.717
 ≥65 18 4 (22.2) 14 (77.8)  
Gender
 Male 81 22 (27.2) 59 (72.8) 0.295
 Female 9 1 (11.1) 8 (88.9)  
T stage
 T1 + T2 64 17 (26.6) 47 (73.4) 0.731
 T3 + T4 26 6 (23.1) 20 (76.9)  
N stage
 N0 63 16 (25.4) 47 (74.6) 0.958
 N1–3 27 7 (25.9) 20 (74.1)  
M stage
 M0 88 23 (26.1) 65 (73.9) 0.402
 M1 2 0 (00.0) 2 (100.0)  
Clinical stage
 I + II 48 13 (27.1) 35 (72.9) 0.825
 III + IV 40 10 (25.0) 30 (75.0)  
Recurrence
 No 33 15 (45.5) 18 (54.5) 0.001*
 Yes 57 8 (14.0) 49 (86.0)  
  1. *P value <0.05 was considered statistically significant (Student’s t test for continuous variables and Pearson’s chi-square test for variables). SD represents the standard deviation. The tumor stage, tumor, lymph node, and distal metastasis status were classified according to the international system for staging HNSCC